Blackstone Inc’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Blackstone Inc’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,708	Closed	-$570K	–	203
2023 Q4	$570K	Buy	+9,708	New	+$546K	﹤0.01%	135

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Blackstone Inc's MRTX Position: Q1 2024 in Review

Blackstone Inc sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 9,708 shares — an estimated $570K sold.

Blackstone Inc first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $570K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Blackstone Inc reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Blackstone Inc sold 9,708 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $570K.
Blackstone Inc first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Blackstone Inc's Mirati Therapeutics, Inc. Common Stock position peaked at $570K in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Blackstone Inc's 13F filing for Q1 2024, filed 15 May 2024.